-
GSK-923295: A Mitotic Perturbation Tool
2026-08-25
GSK-923295 is a CENP-E inhibitor that helps separate motor-dependent chromosome congression from centromere-architecture defects. This article presents an assay-design framework linking mitotic imaging, biochemical mechanism, and translational cancer research evidence.
-
ARCA Capped mRNA Synthesis Kit | K1406
2026-08-25
Learn how HyperScribe™ Co-transcription mRNA Synthesis Kit Plus (ARCA, T7), SKU K1406, can standardize capped, polyadenylated mRNA preparation for cell-based viability, proliferation, cytotoxicity, and translation studies. This scenario-driven guide connects mRNA design, workflow controls, interpretation, and practical kit selection to current RNA vaccine research.
-
Tacrolimus (FK506) in Immune Assay Workflows
2026-08-24
Tacrolimus (FK506) gives researchers a precise way to suppress calcineurin-dependent T-cell activation, cytokine release, and immune-cell signaling. This workflow-focused guide connects dose selection and solvent control with transplantation immunology research, autoimmune disease models, and metabolic-stress assay design.
-
Cyanidin Chloride for Reliable Cell Assays
2026-08-24
A scenario-based guide to using Cyanidin Chloride (SKU N2525) in viability, proliferation, cytotoxicity, and oxidative stress workflows. It connects product specifications with assay controls, fresh-solution handling, optical interference testing, and cautious interpretation of antioxidant effects.
-
Cell Cycle Assay Kit for DNA Content Analysis
2026-08-23
Use the Cell Cycle Assay Kit (Catalog No. K2263) to convert PI-based DNA content into actionable G0/G1, S, and G2/M profiles, while also monitoring apoptosis through the sub-G1 population. Its fixed-cell workflow is suited to treatment-response studies, cancer research cell proliferation, and mechanistic experiments that need a quantitative flow cytometry endpoint.
-
Pseudo-UTP: Designing Better mRNA Translation
2026-08-22
Pseudo-modified uridine triphosphate is more than a chemical substitute for UTP: it is a design variable that can influence RNA persistence, translation, innate immune sensing, and analytical confidence. This thought-leadership perspective connects pseudouridine biology with translational workflow strategy, using published evidence to clarify where Pseudo-UTP adds value and where researchers must avoid overgeneralization.
-
MLN2238: Proteasome β5 Subunit Inhibitor
2026-08-21
MLN2238 is a reversible proteasome β5 subunit inhibitor with nanomolar biochemical potency and additional activity at β1 and β2 sites at higher concentrations. Its proteasome-stress response has also been studied through CREB, ROS, and JNK signaling in cellular and Drosophila models.
-
PDHA1 Succinylation Drives α-KGA Immune Escape
2026-08-20
A Nature Communications study identifies PDHA1 lysine 83 succinylation as a metabolic switch in cholangiocarcinoma that increases α-ketoglutarate accumulation and suppresses macrophage antigen presentation through OXGR1–MAPK signaling. The work connects tumor metabolic reprogramming with immune escape and provides a preclinical rationale for combining succinylation-targeting strategies with gemcitabine and cisplatin.
-
Baicalin Methyl Ester and the Next Gut-Barrier Playbook
2026-08-20
Baicalin methyl ester offers translational researchers a mechanistically anchored approach to LPS-induced intestinal barrier damage research. This article connects P65/TNF-α/MLCK/ZO-1 biology with assay design, formulation strategy, evidence standards, and a cautious path toward gut-barrier therapeutics.
-
Indole-3-pyruvic Acid: From Flux to Function
2026-08-19
Indole-3-pyruvic acid connects tryptophan metabolism with auxin formation, fungal development, and AhR-linked immune signaling. This practical guide translates pathway evidence into better metabolite assays, controls, and cross-domain interpretation.
-
Betaine Hydrochloride: From Salt to Assay Variable
2026-08-19
Betaine hydrochloride can be more than a soluble laboratory compound: it can function as a deliberately controlled variable in enzyme, protease, cell culture, and molecular biology workflows. This article connects its physicochemical behavior with the orthogonal assay strategy used in a 2025 oridonin–esophageal cancer study.
-
Bardoxolone Methyl for Redox Assays
2026-08-18
Build more informative oxidative stress and cancer experiments with Bardoxolone methyl, a dual-action CDDO methyl ester that activates Nrf2 while suppressing NF-kB signaling. This workflow connects pathway validation with thioredoxin, ribonucleotide reductase, and CHK1-inhibitor sensitivity assays, while addressing formulation, timing, and interpretation challenges.
-
Catalpol Review: Cancer Mechanisms and Evidence
2026-08-18
A 2025 Phytotherapy Research review synthesizes preclinical evidence that catalpol may influence cancer-cell proliferation, apoptosis, metastasis, inflammation, and oxidative stress across multiple tumor types. Its main practical value is a pathway-oriented framework for interpreting in vitro and animal findings while emphasizing that clinical efficacy, standardized dosing, and human safety remain unestablished.
-
Anti-ROR1 Antibody: Mechanism to Assay Design
2026-08-17
Anti-ROR1 Antibody (Zilovertamab) enables target-specific investigation of ROR1 biology, while a recent deoxynivalenol study illustrates how causal perturbation can strengthen mechanistic assays. This guide connects binding validation, pathway analysis, and evidence boundaries without conflating oncology and hepatotoxicity models.
-
AICAR for Reliable AMPK Assays
2026-08-17
This scenario-driven guide explains how AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside), SKU A8184, can improve experimental control in cell viability, proliferation, cytotoxicity, and metabolic-stress studies. It covers assay compatibility, solution preparation, interpretation of AMPK-dependent effects, and practical vendor-selection criteria.